🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying the combination of anakinra and axicabtagen...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-10-01
Trial ID
NCT04150913
Treatments Being Tested
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
To learn about the safety of a drug called axicabtagene ciloleucel given in...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-01-08
Trial ID
NCT06043323
The goal of this clinical study is to learn more about the study drug, axic...
Status
Completed
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2022-08-09
Trial ID
NCT05459571
Treatments Being Tested
The goal of this clinical study is to compare the study drug KITE-753 versu...
Status
Recruiting
Location
City of Hope Arizona
Start Date
2026-05-22
Trial ID
NCT07479797
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of e...
Status
Recruiting
Location
Zhujiang Hospital
Start Date
2027-02
Trial ID
NCT06902012
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2019-11-05
Trial ID
NCT04002401
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner Health MD Anderson Cancer Center
Start Date
2019-01-29
Trial ID
NCT03761056
Treatments Being Tested
A multicenter, open-label expanded access protocol for the treatment of sub...
Status
Approved For Marketing
Location
City of Hope
Start Date
TBD
Trial ID
NCT03153462
Treatments Being Tested
Diffuse large B-cell lymphoma is the most commonly occurring subtype of non...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-03-12
Trial ID
NCT07052305
Treatments Being Tested